EPIC: A Phase 3 Trial of Ponatinib Compared With Imatinib in CP-CML Patients
Titel:
EPIC: A Phase 3 Trial of Ponatinib Compared With Imatinib in CP-CML Patients
Auteur:
Lipton, Jeffrey H. Chuah, Charles Guerci-Bresler, Agnes Rosti, Gianantonio Simpson, David Lustgarten, Stephanie Rivera, Victor M. Clackson, Tim Haluska, Frank G. Baccarani, Michele Cortes, Jorge E. Guilhot, Francois Hochhaus, Andreas Hughes, Timothy P. Kantarjian, Hagop Shah, Neil P. Talpaz, Moshe Deininger, Michael W.